Award
National Institute of Diabetes and Digestive and Kidney Diseases 5R01DK130238-05
Pharmacogenetics of the Response to a GLP1R Agonist
Recipient
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH
Award Amount
$672,063.00
Ceiling
$672,063.00
Awarded
December 04, 2025
Identifier
5R01DK130238-05
NIH awarded a grant for pharmacogenetics research on GLP1R agonists to study diabetes treatment, including genetic studies and clinical trials, with a budget of $672,063 for fiscal year 2026.
Description
This is a NIH grant project focused on pharmacogenetics related to GLP1R agonists for diabetes treatment. The project involves genetic studies, clinical trials, and biomarker identification. The award is for the fiscal year 2026, with a total budget of $672,063. The project duration is from December 1, 2025, to November 30, 2026.